Skip to main content

Peters William J's Form 4 filing

Amphastar Pharmaceuticals, Inc. (AMPH) · filed Aug 11, 2026

Accession no.
0001263136-26-000012
Filed
Aug 11, 2026, 4:57 PM ET
Trade date
Aug 7, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $183.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Peters William JCIK 0001263136Director, Officer (CFO, EVP & TREASURER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 7, 2026Common StockMOption exerciseAcquired+5,053$19.79+$99,998.87181,026Direct
Aug 7, 2026Common StockSSaleDisposed−8,180$22.48−$183,886.4172,846Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 7, 2026Common StockMOption exerciseDisposed−5,053$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)